Heart failure: The cardiovascular epidemic of the 21st century

European Heart Journal

Volumn 36, Issue 7, 2015, Pages 395-397

  Lüscher, Thomas F ^a  

^a University Hospital of Zurich   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; PLACEBO; SACUBITRIL PLUS VALSARTAN;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; EPIDEMIC; EXERCISE; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; PRIORITY JOURNAL; REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; VALVULAR HEART DISEASE;

EPIDEMICS; HEART FAILURE; HUMANS;

EID: 84935138166     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv004     Document Type: Review

References (28)

1. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 2014;35:2950-2959.
2. Ramsay SE, Whincup PH, Papacosta O, Morris RW, Lennon LT,Wannamethee SG. Inequalities in heart failure in older men: prospective associations between socioeconomic measures and heart failure incidence in a 10-year follow-up study. Eur Heart J 2014;35:442-447.
3. Komajda M, Lam CS. Heart failure with preserved ejection fraction: a clinical dilemma. Eur Heart J 2014;35:1022-1032.
4. Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, Hillege HL, van Veldhuisen DJ, van Gilst WH. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a communitybased cohort: 11-year follow-up of PREVEND. Eur Heart J 2013;34:1424-1431.
5. Messerli FH, Messerli AW, Luscher TF. Eisenhower's billion-dollar heart attack-50 years later. N Engl J Med 2005;353:1205-1207.
6. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, WijnsW, Zahger D; ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
7. Steg G, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van't Hof A, Widimsky P, Zahger D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-2619.
8. Norscini G, Vagnarelli F, Taglieri N et al. Mid-term and long-term mortality associated with heart failure in patients hospitalized for acute coronary syndromes. Eur Heart J http://eurheartj.oxfordjournals.org/content/34/suppl-1/P1342.
9. van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad JJ, Boersma E. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients. Eur Heart J 2012;33:2088-2097.
10. Yu CM, Hayes DL. Cardiac resynchronization therapy: state of the art 2013. Eur Heart J 2013;34:1396-1403.
11. Burnier M, Vuignier Y, Wuerzner G. State-of-the-art treatment of hypertension: established and new drugs. Eur Heart J 2014;35:557-562.
12. Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC Jr, Crowley K, Goto S, Ohman EM, Bakris GL, Perlstein TS, Kinlay S, Bhatt DL; REACH Registry Investigators. Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. Eur Heart J 2013;34:1204-1214.
13. Zannad F, De Ferrari GM, Tuinenburg AE, Wright D, Brugada J, Butter C, Klein H, Stolen C, Meyer S, Stein KM, Ramuzat A, Schubert B, Daum D, Neuzil P, Botman C, Caste MA, D'Onofrio A, Solomon SD,Wold N, Ruble SB. Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial. Eur Heart J 2015;36:425-433.
14. Camm AJ, Savelieva I. Vagal nerve stimulation in heart failure. Eur Heart J 2015;36: 404-406.
15. McMurray J, Packer M, Desai A, Gong J, Greenlaw N, Lefkowitz M, Rizkala A, Shi V, Rouleau J, Solomon S, Swedberg K, Zile MR, Andersen K, Arango JL, Arnold M, Bělohlávek J, Böhm M, Boytsov S, Burgess L, CabreraW, Chen CH, Erglis A, Fu M, Gomez E, Gonzalez A, Hagege AA, Katova T, Kiatchoosakun S, Kim KS, Bayram E, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires F, Refsgaard J, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire I, Starling RC, Vinereanu D, Teerlink JR, Wong R; on behalf of the PARADIGM-HF Committees and Investigators. A putative placebo analysis of the effects ofLCZ696on clinical outcomes in heart failure. Eur Heart J 2015;36:434-439.
16. Califf RM. LCZ696: too good to be true? Eur Heart J 2015;36:410-412.
17. Ruwald AC, Kutyifa V, Ruwald MH, Solomon S, Daubert JP, Jons C, Brenyo A, McNitt S, Do D, Tanabe K, Al-Ahmad A,Wang P, Moss AJ, ZarebaW. The association between biventricular pacing and cardiac resynchronization therapydefibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling. Eur Heart J 2015;36:440-449.
18. Lubitz SA, Singh JP. Biventricular pacing: more is better! Eur Heart J 2015;36:407-409.
19. Kodali S, Pibarot P, Douglas PS, Williams M, Xu K, Thourani V, Rihal CS, Zajarias A, Doshi D, Davidson M, Tuzcu EM, StewartW,Weissman NJ, Svensson L, Greason K, Maniar H, Mack M, Anwaruddin S, Leon MB, Hahn RT. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J 2015; 36:449-456.
20. Maisano F, Taramasso M, Nietlispach F. Prognostic influence of paravalvular leak following TAVI: is aortic regurgitation an active incremental risk factor or just a mere indicator? Eur Heart J 2015;36:413-415.
21. Voors A, Ruschitzka F. The year in cardiology: heart failure 2014. Eur Heart J 2015;36:421-424.
22. Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O'Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM; TOPCAT Investigators. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 2014;370:1383-1392.
23. Filippatos G, Teerlink JR, Farmakis D et al. Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial. Eur Heart J 2014;35(16):1041-1050.
24. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014;371:993-1004.
25. Pierard LA, Vahanian A. The year in cardiology 2014: valvular heart disease. Eur Heart J 2015;36:416-420.
26. Hoffmann R, Brehmer K, Herpertz R, Marx N, Autschbach R, Lotfi S. Long-term outcome after TAVI and the impact of new left bundle branch block or pacemaker implantation on survival. Eur Heart J 2015; http://eurheartj.oxfordjournals.org/content/34/suppl-1/P5424.
27. Schoenenberger AW, Stortecky S, Neumann S, Moser A, Jüni P, Carrel T, Huber C, Gandon M, Bischoff S, Schoenenberger CM, Stuck AE, Windecker S,Wenaweser P. Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). Eur Heart J 2013;34:684-692.
28. Sinning JM, Neugebauer A, Ghanem A et al. Incidence, predictors, and prognostic value of periprocedural myocardial injury after TAVI. Eur Heart J 2015; http://eurheartj.oxfordjournals.org/content/34/suppl-1/P5400.